Pharmafile Logo

DDI LLC

DDi is a prominent Technology partner to the Life Sciences industry. DDi has built its solution competency with a unique blend of functional and domain expertise to serve the technology needs of global clients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

IPG Health Medical Communications

We are the world’s most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity and technology to exceptional medical communications solutions for our clients.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

 Latest Content from PMHub 

Pegasus Moves to Brighton

Top UK Healthcare Communications Consultancy Moves to Brighton

UX: Designing Human Experiences

Applying science to the creative process to improve lives

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

07 Good Pharma

Better for patients, better for business

05 Social Media: A Health Hazard?

The case to embrace going social

Creating a Lifeline to the New Digital User

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.